of rifampicin controlled release formulations have been developed to improve clinical efficacy of the drug [3, 8, 9] . Basak et al. studied the release profile of rifampicin from polyurethane coated implant film materials [8] . This profile was characterized by a burst release followed by a sustained release [8] . The release of the rifampicin from the copolymered styrene and, ether methyl or ethyl methacrylate films was also studied [9] . Both sets of the polymer films released the drug at a high rate in the initial phase followed by a significantly slower rate [10] . Ruggeri et al. observed sustained release of rifampicin for the drug entrapped in the polyurethane film, containing poly(ethylene glycol) at different molecular weight [4] .
The release of rifampicin was also studied in ethylcellulose coated nonpareil beads [7] . These beads have been successfully used to maximize drug absorption, or to control the bioavailability of the active drug. It was found that the rifampicin release from the coated beads depends on the permeability of the polymer used. The nearly complete release of the contained rifampicin took 12 hours [7] .
Polyurethanes have been extensively used for various biomedical applications such as aortic grafts [10] , heart valves [11], pacing leads insulation [12] , cardiac catheters [13] and controlled drug release devices [14] due to their good physical properties and good biocompatibility [15] .
The polyurethanes were used for controlled delivery of the various pharmaceutical agents, including caffeine [16] , rifampicin [4] and nystatin [14] . Many of these systems are based on a physical combination of a drug with polymers. The kinetics of drug release is generally controlled by diffusion phenomena through the polymer [16] . Different studies report that the diffusion-controlled release of antibiotics from the polyurethane matrices depends on the solubility of the antibiotics and their concentration in the matrix [17] . The drug release is controlled by the asymmetric membrane that forms either in vitro or in vivo by polymer phase inversion [18] . The rate of drug release from the polyurethane matrix can also be altered by using pore formers incorporated into a polyurethane matrix [3] . Also, the morphology influences the drug delivery rates and in relation with surface wettability, determines the biological properties of the films [19] .
This paper presents the preparation of two poly(ester ether urethane)s with different molar concentrations of urethane groups (1.54 mmol g -1 and 2.44 mmol g -1 , respectively) for the sustained delivery of an antiinfective agent and their chemistry and morphology influence on the rifampicin released from their matrixes. The polyurethanes rifampicin solutions were used as asymmetrical microporous membranes by phase inversion method. They have poly(ethylene glycol) on the macromolecular chain, a water soluble component, which tends to enhance the release quantity of the rifampicin from their matrix.
Concentrations mentioned above were chosen since it is well-known that up to 2.2 mmol g -1 of urethane polymer is a mixture of hard-hard and hard-soft segments. Above this concentration a large part of the hard-soft segments passes into hard-hard crystallites [20] , which were characterized by ATR-FTIR, SEM, AFM, contact angle, UV-vis and water uptake. The application of the two polyurethane membranes with rifampicin shows bacterial activity with S. Epidermidis RP 62 A and P. Aeruginosa ATCC 1544 and biological test.
Experimental procedure

Materials
Poly(ethylene glycol) (PEG), Mn 2000 Da, (SigmaAldrich, UK); poly(butylene adipate)diol (PBA) Mn 2000 Da, synthesized in our laboratory; 1,4-butane diol (BD), (Sigma-Aldrich, UK) and 4,4'-diphenylmethane diisocyanate (MDI), (Sigma-Aldrich, UK) were used as received. Dimethylformamide (DMF), (Sigma-Aldrich, UK). Rifampicin (R) was offered by S.C. Antibiotice SA Iasi and was used as received. All other chemicals were of analytical reagent grade.
Methods
Polyurethanes synthesis
The poly (ester ether urethane)s were synthesized from PBA, PEG, MDI and BD in a solution of DMF according to the previously published method [20] . The polyurethane PU 1 has the components ratio of PBA:PEG:MDI:BD =0.875:0.125:2:1, with a urethane concentration of 1.54 mmol g -1 and polyurethane PU 2 has the ratio of PBA: PEG: MDI: BD = 0.875:0.125:4:3 with a urethane concentration of 2.44 mmol g -1 . The PBA and PEG were dehydrated in vacuum 0.1-0.2 mmHg, at 80°C for 3 hours. The reaction was carried out under stirring with MDI at a temperature of 80°C for an hour, then the DMF solution and the BD were added at 60°C temperature for 6 hours. The polymerization was stopped with a solution of 10 mL ethyl alcohol: DMF 1:1 (v/ v) at the viscosity of 7000 cP for PU 1 and 7200 cP for PU 2 , respectively at 60°C. The synthesis route of the poly(ester ether urethane)s is presented in Scheme 1.
Preparation of polyurethane solutions with rifampicin
The 78 mg rifampicin was dissolved in the 1.5 mL DMF. After complete dissolution of the drug, the homogenous solutions were poured into 5 g polyurethane DMF solution (30% w/w PU in DMF). The solutions were stirred vigorously for 3 hours and then poured into Petridishes (Ø=110 mm) and left 24 hours. Two types of polyurethane solutions with rifampicin were obtained.
Preparation of polyurethane membranes with rifampicin
Polyurethane solutions with rifampicin (R) were processed as membranes by using the phase inversion method initiated by precipitation in non-solvent [20] .
The deionized water at 45°C was poured over the polyurethane solution with rifampicin and kept under these conditions until the membrane separated entirely from the Petri dish. Then the membranes were dried in a vacuum oven at 25°C and 0.02 mbar to a constant weight. The percentage of rifampicin release from the membranes in distilled water was calculated using the slope and the intercept obtained from the standard rifampicin curve, in bi-distilled water. The proportions of rifampicin remained in the membranes, were: PU 1 -R 2.6% and for PU 2 -R 2.7%, respectively.
Characterizations
UV-VIS analysis
The UV-VIS measurements were performed using a JENWAY type 6505 spectrophotometer (Bibby Scientific Ltd., England).
ATR-FTIR analysis
The membranes were studied by ATR method by means of a FT-IR DIGILAB, a Scimitar Series (USA) spectrometer with a resolution of 4 cm −1 . A crystal SeZn with refraction index of 2.4 was used. The spectra were recorded over 600-4000 cm −1 domain at room temperature and the penetration degree was in the range of about 2-3 μm.
DSC analysis
Differential scanning calorimetry (DSC) measurements were performed by means of a Pyris Diamond (Perkin Elmer) instrument. The samples mass of 6-8 mg were placed into aluminum foil pans. DSC curves were recorded in nitrogen atmosphere (20 mL min -1 flow) with a heating rate of 5°C min -1 from −100 to −40°C temperature range. Glass transition temperature (Tg) was taken as the inflexion point of the DSC curve. Two runs were performed for each sample. High purity (98%) indium with melting temperature at 156.68°C and melting enthalpy of 28.4 J g -1 was used as a reference.
SEM analysis
Surface morphology of the sections was examined before and after release of rifampicin using a SEM/ESEM FEI Quanta 200 microscope equipped with EDAX Si (Li) X-ray detector and Gatan Alto Cyro stage, operating at 20 kV. Samples were mounted on graphite supports and observed under varying degrees of magnifications.
Images of the sections were taken from the most relevant aspects. Image J version 1.43u (available from the National Institute of Health, USA) software was used to calculate the average size of pores and their distributions.
AFM analysis
AFM measurements were performed in the tapping mode in air at room temperature, using a Scanning Probe Microscope (Solver PRO-M, NTMDT, Russia) Scheme 1. Synthesis of the polyurethanes PU 1 and PU 2 .
with commercially available NSG10/Au Silicon cantilevers. The manufacturer reported values for the probes tip radius of 10 nm, and typical force constant of 11.5 N m -1 . The cantilever is oscillated at a frequency of 183.228 kHz in the tapping mode. The roughness factor was calculated as the ratio of real surface area to the geometric surface with SPIP4.8.4 software [21] . The three-dimensional image analysis of the surface properties using the surface roughness parameter was obtained.
Contact angle measurements
Contact angles were measured by the static drop method at room temperature, using a KSVCAM 101 goniometer, equipped with a special optical system and a CCD camera connected to a computer to capture and analyze the contact angle (five measurements for each surface). A drop of liquid (~1 μL) was placed on the previously prepared plate of substratum, and the image was immediately sent via the CCD camera to the computer for analysis. Temperature and humidity were constant during the experiment (23°C and 68% respectively).
Water uptake measurements
The dried and pre-weighed polyurethane membranes were immersed into phosphate buffer (PB) for 24 hours at 37 o C. During that time the polymer attained equilibrium swelling. Then the membranes were taken out and reweighed after wiping the surface gently at a certain time intervals. The degree of the water uptake was calculated as follows: (1) where, W d and W w are the weights of dry and wet polyurethanes membranes, respectively. The average value of three measurements from different samples is reported.
Cell culture
HDF (Human dermal fibroblast) were isolated from human skin using the explant method. Briefly, 1 cm 2 of human skin was sterilized in 3-step washing procedure in the Dulbecco's Modified Eagle Media (DMEM -Sigma), with decreasing antibiotic concentration as follows: 1 st step -10 minute mixture in 4% penicillin/streptomycin/ neomycin (PSN) solution (Sigma) in DMEM media; 2 nd step -10 minute mixture in 2% PSN solution and 3 rd step -10 minute mixture in DMEM without PSN. After the last washing step, the hypodermic part of the skin was removed. The dermis together with the epidermis were cut in small (1-2 mm) pieces, then placed with the dermis part down upon a thin layer of the fetal bovine serum (FBS -Sigma). Small amount of DMEM supplied with 10% FBS and 1% PSN was added to cover tissue pieces. After 2-3 weeks of culturing at 37 o C and 5% CO 2 atmosphere, with media refreshing every 3 days, the cells were transferred on a culture flask with 25 cm 2 surface area.
MTT cell Proliferation/Viability assay
In vitro cytotoxicity tests of the polyurethane membranes were performed with yellow MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; a tetrazole) tests. Before cell proliferation assay, polyurethane membranes were sterilized for 15 minutes in 70% v/v ethyl alcohol solution, washed in sterile phosphate buffer (PBS -Sigma) and then incubated in DMEM media at 37 o C and 5% CO 2 atmosphere for 48 hours. After that, the polyurethanes membranes were transferred on the 24-wall cell culture plate. One sample was used for each plate wall in the triplicate mode. Upon polyurethanes membranes, an initial concentration of 40 000 HDF cells/wall was added and incubated for 24, 48 and 72 hours. After each desired incubation time, culture media from the wells was removed and 0.5 mL of MTT solution in DMEM was added to each (control and sample plated) wall. The final concentration of MTT/wall was 0.25 mg mL -1 . The culture plate was incubated for 3 hours at 37 o C in dark conditions. After incubation, MTT solution was removed and the insoluble formazan crystals were dissolved by adding 0.5 mL wall -1 of 2-propanol. The absorbance of the colored solution obtained was quantified by the spectrophotometer measuring at λ=570 nm. The cell viability was normalized to that of fibroblasts cultured in the media with negative control (without material). The polyurethanes that displayed at least 70% of formazan color intensity from control walls was considered to be noncytotoxic.
In vitro drug release
The in vitro drug release kinetics of the polyurethane membrane with rifampicin was carried out as follows. The experiments were performed in a shaking bath thermostated at 37°C by immersing 10 mm 2 square samples (a sealed glass vial of the phosphate buffer (PB) (pH 7.4). The release was made by changing the phosphate buffer at 24 hours and at a certain time intervals; aliquots (1 mL) of the sample were taken out periodically to determine drug concentration. Absorbance from blank membranes (PU 1 and PU 2 without drug) as a function of time were systematically measured and subtracted from the absorbance value of the rifampicin membranes. This measurement ensured that any unreacted material that leached into external solvent, that might occur during the time of the release experiments, was taken into account of. Released rifampicin amount was monitored using a UV-VIS Spectrophotometer JENWAY type 6505. The absorbance of the rifampicin was determined at a wavelength of 475 nm [7] . The amount of rifampicin released from the membranes at a given time was calculated using the slope and the intercept obtained from the standard rifampicin curve in phosphate tampon pH=7.4, prepared for pure drug in the appropriate concentration region. Experiments were performed in triplicate and the average value was considered.
Antibacterial activity
The antibacterial activity of the polyurethane membranes with rifampicin was evaluated in vitro by a modified KirbyBauer test [3] . Since rifampicin is a broad spectrum antibiotic, the activity was tested against a gram positive Staphylococcus Epidermidis RP 62A, a gram negative Pseudomonas Aeruginosa ATCC 1544. Mueller-Hinton milieu was used throughout the test. Sterile molten Mueller-Hinton agar was poured into sterile disposable Petri dishes (Ø=100 mm). Cultures were prepared in a sterile Mueller-Hinton broth and were vortexed for 24 hours at 37°C. The bacterial suspensions (10 7 CFU mL -1 ) were transferred individually onto the surface of Mueller-Hinton agar plates. The disks with 1.8 cm of PU membrane were placed on the surface of these Petri plates. After incubation at 37°C for 24 hours, the inhibition zone of the bacterial growth around the polyurethane membrane with rifampicin was measured from one edge of the zone of inhibition to the opposite edge, including the diameter of the disk. After that measurement, all disks were transferred to another seeded Petri plates. The colony forming unit (CFU mL -1 ) of each dilution was determined after a serial dilution and colonies were counted on Mueller-Hinton agar. The rifampicin diffused out and inhibited the growth of bacteria resulting in the change in a diameter of inhibition zone.
Results and discussion
ATR-FTIR analysis
Infrared spectroscopy is an important tool used to characterize the interactions of two or more components in a polymer [22] . It is well known that the properties of polyurethanes are mostly defined by the two phase structure strongly related to hydrogen bond formation [22] . Fig. 1 presents the ATR-FTIR spectra of the synthesized polyurethane membranes and the polyurethane membranes with rifampicin. The ATR-FTIR spectra of the polyurethanes were interpreted using methods reported in the literature [14, 20] . The absorption bands with maxima at 3337 and 3331 cm -1 respectively, are assigned to ν(N-H) stretching bands and the peaks at 2955 and 2957cm -1 , are the asymmetric and symmetric stretching vibration ν(CH 2 ) asym, ν(CH 2 ) sym of the polyurethane Respectively. The free carbonyl groups of the polyester chain and urethane groups ν(C=O) are at 1726 and 1727 cm -1 respectively, and the stretching vibrations of bonding carbonyl groups ν(C=O) of urethane structure is at 1714 and 1700 cm -1 respectively. Also, the ATR-FTIR displays a broad intense absorption band with the maximum at 1596 cm -1 for the stretching vibration ν(C=C) of the aromatic ring. The peaks at 1530 cm -1 are characteristics to the amide II caused mainly by deformation vibrations δ(N-H) associated with the stretching vibrations ν(C-N). At 1220 and 1221cm
is the amide III with the same type of vibrations δ(N-H) and ν(C-N) respectively. The intensive peak observed at 1077 cm -1 can be assigned to the stretching vibration of ν(C-O-C) from the aliphatic ether.
The characteristic peaks of rifampicin were identified at 3439 cm -1 for the stretching vibration of hydrogen free. The asymmetric and symmetric stretching vibration ν(CH 2 ) asy , ν(CH 2 ) sym are at 2970 and 2917cm -1 and the stretching vibration of free and bonded carbonyl ν(C=O) are at 1734 and 1710 cm -1 [9]. The intense peak of the stretching vibration ν(C=C) is at 1565 cm -1 and the peak of stretching vibration ν(C-O-C) is present at 1020 cm -1
[9]. We note that Form II of rifampicin with two peaks in the carbonyl region at 1714 and 1734 cm -1 was used, the form of the drug consistent with crystalline was observed [9] . Table 1 shows the assignments of the major ATR-FTIR absorption bands in the polyurethanes membranes, which demonstrate the presence of the expected functional groups. The absorptions bands of rifampicin overlap with the absorption bands of the polyurethanes membranes that have the same type of groups and vibrate at the same wavelength.
In order to establish whether the polyurethane membrane with rifampicin undergoes spectral changes, the pure component spectra were taken into account and on the basis of the additivity law the calculated spectra of the polyurethane membranes with rifampicin were obtained and compared with the experimental ones. For an immiscible polyurethane membrane the additive spectrum is overlapped with the experimental one, while miscible or partially miscible polyurethane membranes with rifampicin show frequency shifts, band broadening and changes in the intensity of some bands caused by conformational changes and intermolecular interactions between components [22] . The interactions like hydrogen bonds could be formed between carbonyl, urethane and hydroxyl groups of rifampicin [22] . Comparing the calculated and experimental spectra of the polyurethane-rifampicin membranes we found that the bands located at 3337 and 3329 cm -1 (N-H stretching bonding vibrations), 2958 cm -1 (CH 2 asymmetric stretching vibration), 1729 cm -1 and 1703 cm -1 (C=O free and bond carbonyl stretching vibration), 1161 and 1171 cm -1 respectively (C-O stretching vibration in ether group) with the same vibrations of PU 1 , PU 2 are changed, caused by the presence of rifampicin in the PU 1 -R and PU 2 -R matrix. The relation ratio (A bonded C=O :A C=O ) between the area of the bonded carbonyl absorption band to the areas of the carbonyl absorption band (free carbonyl + bonded carbonyl) was calculated in the carbonyl region of 1800-1630 cm -1 . Results are presented in Table 2 . The changes of the polyurethane structure with rifampicin can be attributed to the presence of the hydrogen bonds.
DSC analysis
The values of glass transition temperature, T g, are at -33.95 o C for PU 1 and -41.25 o C for PU 2 (Fig. 2) and are lower than the values of T g for PU 1 -R and PU 2 -R. The presence of rifampicin in the polyurethane matrix increase in the glass transition temperature in both series of polyurethanes and shows that the rifampicin structure affects the polyurethanes matrix. This effect may be due to the hydrogen bonds between rifampicin and urethane groups, as we have seen in the ATR-FTIR analysis. The same phenomenon for a concentration of 3% rifampicin was also analyzed by other authors, who observed that the effect of the Tg increase is in conformity with the ability of the rifampicin to form hydrogen bonds [23, 24] .
Water uptake
The water uptake degree of the polyurethane membranes in phosphate buffer pH=7.4 is presented in Fig. 3 . In theory a higher water uptake of the polymer causes a higher drug diffusion from the polymer matrix [25] . The polyurethane water uptake decreased with increasing hard segment in the polymer composition from 1.54 mmol g -1 to 2.44 mmol g -1 (Fig. 3) . Thus, the release of the rifampicin will have to be faster for PU 1 -R.
Contact angles and surfaces free energy
Analysis of the surface properties of polyurethanes is very important to establish biocompatibility of the polymeric materials [26] . These may be controlled through the quantity of hard segment in the polyurethane composition. The contact angle has different values for each type of polyurethane and is determined by the interaction between the three interfaces described by Young's equation: (2) where γ SV is the free energy of the surface, γ SL is the interfacial tension between the solid and the drop, γ LV is the liquid-vapour surface tension and cos θ is the contact angle of the drop with the surface [27] .
Also, according to the method of Owens-WendtRabel and Kaelbe [27, 28] , the surface energy (γ SV ) results from the polar and disperse interactions: The values of the contact angle for the polyurethane and rifampicin polyurethane membranes are presented in Table 3 . The hydrophilic character of the PU 1 polyurethane could be explained by the differences in the chemical structure and in the surface configuration [30] . It is well known that any increase of the crystallinity of polymer causes an increase of the hydrophobic character of the polymers [31] . Rifampicin is considered a hydrophilic drug, is soluble in pH=7.4 phosphate buffer [32] . In Table 3 , the values obtained for the contact angle decrease gradually with the rifampicin concentration, obviously due to the drug introduced. The work of adhesion (W a ) and superficial tension (γ SV ) are shown in Table 3 . The increase in the surface energy can be explained by the presence of rifampicin functional groups. The value of the contact angle for PU 1 -R is 70.26 o and for PU 2 -R is 79.94 o . This phenomenon could be explained by higher release rate of rifampicin for PU 1 -R.
Morphological analyses of the membranes
The SEM images of the rifampicin polyurethane membranes, before and after release, are presented in Fig. 4 . The water penetration through the microporous membranes is a complex mechanism, in addition to a simple transport of water molecules through microcapillaries [22] . The membranes polyurethane with rifampicin has interconnected pores, non-individual circular shape pores with various sizes.
After release of rifampicin for PU 1 -R the range of pores with diameters in the range 2.5-7.5 μm decreased with a percentage of 1.72-11.5% and the pores with a diameter of 25, 35, 45 μm increased with 0.52, 7, 2 and 2.7%, respectively. Also in the case of PU 2 -R pores with initial diameter of 15, 25, 35 μm increased on 3, 11, 7%, respectively. For PU 1 -R after release, the highest portion is 35% for the 15 μm pores and the lowest portion is 0.06% for 75 μm pores. In the case of PU 2 -R the highest portion after release is 31% for the 15 μm and the lowest portion 0.86% for the 55 μm. The behavior mentioned above can be attributed to the release of rifampicin. Thus, the new pores of membrane formed become thinner and larger.
Atomic force microscopy
The surface topography for the polyurethanes membrane with rifampicin was analyzed by means of atomic force microscopy (AFM) (Fig. 5) . The roughness factor for PU 1 -R is 1.03407 and for PU 2 -R is 1.01616. Generally, the rougher surface the larger area for release and this sustains the idea of the surface influence on the rifampicin release [33] . Considering above, the release will be faster for PU 1 -R compared to PU 2 -R.
Cell cytotoxicity
The biocompatibility of the polyurethane membranes was assessed with fibroblastic cells from the human derma. It is known from the specialized literature that this method of assaying cell viability is frequently applied to test toxicity, emphasizing the metabolic activity of cell cultures [34] . The obtained results certify the biocompatibility of the polyurethane materials studied. Fig. 6 presents the results obtained in the cell viability test. The polyurethane membranes are noncytotoxic for human cells. More than 80% of the cell viability analyzed after 24, 48 and 72 hours, have a very good biocompatibility, after the incubation with the cells (Fig. 6 ). Fig. 7 presents the cumulative release of rifampicin from the polyurethane matrix in phosphate buffer pH=7.4 at 37 o C. The release profiles of PU 1 -R and PU 2 -R show an initial "burst" followed by a sustained release of rifampicin from the polyurethane membranes. The release mainly depends on the molar concentrations of the urethane groups and on the surface morphology of the polyurethane membranes with rifampicin: it is significantly higher for the PU 1 -R polyurethane than for the PU 2 -R, (Fig. 7) . The linear regression test for the rifampicin released between 72 and 216 hours shows that PU 1 -R releases 0.0458 μg mL -1 , and PU 2 -R releases only 0.0284 μg mL -1 . The quantities released are higher than the minimum inhibitory concentration (MIC) of the rifampicin for the Gram-positive bacteria (<0.006 μg mL -1 for S. Aureus, <0.0016 μg mL -1 for S. Epidermidis) [35, 36] . A large quantity of urethane groups leads to a prolonged release of the rifampicin. A sustained release of nystatin was also observed for the concentrations of urethane groups 2.5 mmol g -1 [14].
In vitro release study
Antibacterial activity
The antibacterial activity of the polyurethane membranes with rifampicin was assessed for two bacteria -S. Epidermidis RP 62 A and P. Aeruginosa ATCC 1544 -using Muller Hinton agar. The drug quantity released during the first hour is much higher than the minimum inhibitory concentration against the gram-positive and gram-negative bacteria (<0.006 μg mL -1 for S. Aureus [35], <0.0016 μg mL -1 for S. Epidermidis [36] ). The diameter of the inhibition area was assessed by transfer of plates for 216 hours. All polyurethane membranes with rifampicin produced an inhibition zone for a prolonged period in the case of S. Epidermidis and less for P. Aeruginosa, while the controls polyurethanes membranes without rifampicin showed no inhibition zone. P. Aeruginosa presented low inhibition, which confirms the outcomes presented in literature, certifying the resistance of the bacterium P. Aeruginosa to rifampicin [37] . The release of the drug from the two polyurethane membranes is in correlation with the inhibition diameter area, determined for rifampicin polyurethane membranes. The PU 1 -R has a diameter of inhibition area higher than PU 2 -R. In static conditions, the bacterium S. Epidermidis is characterized by a more effective and longer antibacterial activity than the gram-negative P. Aeruginosa bacteria.
Conclusion
The obtained results show that the synthesized polyurethane could be used as sustained release membranes of rifampicin. They can achieve the immediate release of the antibiotic and also prevent further growth of bacteria. The presence of rifampicin in the PU 1 -R and PU 2 -R matrix was confirmed with contact angle, atomic force microscopy (AFM), scanning electron microscopy (SEM), ATR-FTIR and DSC analysis. Those experiments show that the structure of the drug affects the polyurethane matrix. The rifampicin release is mainly dependent on the molar concentrations of urethane groups and also on the surface morphology of the polyurethane membranes with rifampicin. It was found that the release from the polyurethane PU 1 -R is significantly higher than PU 2 -R. The proposed polyurethanes membranes with rifampicin exhibited an antibacterial efficacy against S. epidermidis for a prolonged period of time (at least 9 days). The membranes obtained have promising application as drug delivery matrices, as short-term implants (e.g. catheter membranes) or as long term implants.
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